# Annovis Bio (ANVS) — News

ANVS · NYSE · Stock

Canonical page: https://www.lighthorse.io/tickers/anvs/news

## Recent headlines

- [New deal: Atlas Warehouse lending $Bmark 6NCS +150 area](https://www.ainvest.com/news/deal-atlas-warehouse-lending-bmark-6ncs-150-area-2610) — AInvest Wire, Oct 14, 2026
- [CPBIO renewal of continuing connected transactions, notice of special general meeting](https://www.ainvest.com/news/cpbio-renewal-continuing-connected-transactions-notice-special-general-meeting-2610-19) — AInvest Wire, Oct 13, 2026
  Cancer Prevention & Biotechnology Limited (CPBIO) has announced the renewal of its continuing connected transactions, as disclosed in a recent regulatory filing. The company has also issued a notice of a special general meeting (SGM) to be held on October 30, 2026, for shareholders to consider and…
- [CPBIO renewal of continuing connected transactions, notice of special general meeting](https://www.ainvest.com/news/cpbio-renewal-continuing-connected-transactions-notice-special-general-meeting-2610) — AInvest Wire, Oct 13, 2026
- [Annovis announces partnership with Weave Bio, AI regulatory platform, in preparation of NDA for Buntanetap in Alzheimer’s disease](https://www.ainvest.com/news/annovis-announces-partnership-weave-bio-ai-regulatory-platform-preparation-nda-buntanetap-alzheimer-disease-2609) — AInvest Wire, Sep 23, 2026
- [Annovis Bio - Open-label Alzheimer's study for buntanetap to begin October 2026](https://www.ainvest.com/news/annovis-bio-open-label-alzheimer-study-buntanetap-october-2026-2608) — AInvest Wire, Aug 25, 2026
  Annovis Bio, Inc. (NYSE: ANVS) announced that its open-label extension (OLE) study for Alzheimer’s disease (AD) patients will begin in October 2026 . This study will allow participants who have completed the pivotal Phase 3 trial of buntanetap to continue receiving the investigational therapy. The…

## Similar Stocks

- [ALXO](https://www.lighthorse.io/tickers/alxo) — ALX Oncology Holdings Inc. - Common Stock

---

Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).